Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 07 - 08 symbols : Nvs save search
Agenus Sets Sights on New California Site Near Genentech
Published: 2021-07-08 (Crawled : 20:00) - biospace.com/
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: 0.12%
H: 0.41%
C: 0.33%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -0.42%
H: 0.45%
C: 0.23%
set
Insights on the Osteoarthritis Treatment Global Market to 2029 - Featuring Sanofi, GlaxoSmithKline and Anika Therapeutics Among Others
Published: 2021-07-08 (Crawled : 14:00) - prnewswire.com
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: 0.12%
H: 0.41%
C: 0.33%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -0.42%
H: 0.45%
C: 0.23%
GSK | $39.27 -0.83% 0.01% 2.2M
|
Health Technology
|
| O: -0.89%
H: 0.35%
C: 0.23%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -0.16%
H: 0.18%
C: 0.08%
treatment osteoarthritis
Molecular Partners Reports Continued Progress of Ensovibep Global Clinical Program; Positive in vitro Data Demonstrating Maintained Inhibition of Delta and All Other Known Variants of Concern of SARS-CoV-2
Published: 2021-07-08 (Crawled : 06:00) - globenewswire.com
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: 0.12%
H: 0.41%
C: 0.33%
positive molecular ensovibep sars-cov-2 in vitro
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.